<HashMap><database>biostudies-other</database><scores/><additional><omics_type>Unknown</omics_type><submitter>DESSEN Philippe</submitter><species>Homo sapiens</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-ECPF-TABM-1198</full_dataset_link><project>EurocanPlatform</project><abstract>A recent study of the characteristics of coexisting melanoma and renal cell carcinoma RCC in the same patients supports a genetic predisposition underlying the association between these two cancers. The microphthalmia associated transcription factor (MITF) was proposed to act as a melanoma oncogene; it also stimulates the transcription of hypoxia inducible factor (HIF1A), whose pathway is targeted by kidney cancer susceptibility genes. By sequencing the MITF gene, we detected a germ line missense substitution (p.E318K) in 5 of 62 patients affected with melanoma and RCC. When compared with 1,659 controls, this MITF substitution occurred at a significantly higher frequency in melanoma + RCC patients (p = 1.3x10-4), melanoma -only patients (p = 7.8 x10-5), and RCC-only patients (p = 0.008). O</abstract><repository>biostudies-other</repository><experiment_type>transcription profiling by array</experiment_type><data_source>EurocanPlatform</data_source><pubmed_authors>DESSEN Philippe</pubmed_authors></additional><is_claimable>false</is_claimable><name>IGR_MITF_STUDY_BBRB</name><description>A recent study of the characteristics of coexisting melanoma and renal cell carcinoma RCC in the same patients supports a genetic predisposition underlying the association between these two cancers. The microphthalmia associated transcription factor (MITF) was proposed to act as a melanoma oncogene; it also stimulates the transcription of hypoxia inducible factor (HIF1A), whose pathway is targeted by kidney cancer susceptibility genes. By sequencing the MITF gene, we detected a germ line missense substitution (p.E318K) in 5 of 62 patients affected with melanoma and RCC. When compared with 1,659 controls, this MITF substitution occurred at a significantly higher frequency in melanoma + RCC patients (p = 1.3x10-4), melanoma -only patients (p = 7.8 x10-5), and RCC-only patients (p = 0.008). O</description><dates><release>2016-04-14T14:53:24Z</release><modification>2016-04-14T14:53:24Z</modification><creation>2016-04-14T14:53:24Z</creation></dates><accession>S-ECPF-TABM-1198</accession><cross_references><ArrayExpress>E-TABM-1198</ArrayExpress><EFO>EFO_0000756</EFO><EFO>EFO_0000322</EFO><EFO>EFO_0002890</EFO><ArrayExpress files>E-TABM-1198</ArrayExpress files></cross_references></HashMap>